Press Release

DAY HI:
DAY LOW:
VOLUME:

Copyright West LLC. Minimum 15 minutes delayed.

Webcast Alert: Executives from Aastrom Biosciences, BioCryst Pharmaceuticals, Dendreon, Genentech and Spectrum Pharmaceuticals Will Present at Informed Investors Biotech/Cancer Stocks Forum to be Webcast on Tuesday, December 16, 2003, 9 AM ET

December 12, 2003 at 12:00 AM EST
Webcast Alert: Executives from Aastrom Biosciences, BioCryst Pharmaceuticals, Dendreon, Genentech and Spectrum Pharmaceuticals Will Present at Informed Investors Biotech/Cancer Stocks Forum to be Webcast on Tuesday, December 16, 2003, 9 AM ETSAN FRANCISCO, Dec. 12 /PRNewswire/ -- Informed Investors will webcast the following presentations:
    What:    Aastrom Biosciences, Inc. (Nasdaq: ASTM - ), BioCryst
             Pharmaceuticals, Inc. (Nasdaq: BCRX - ), Dendreon Corp.
             (Nasdaq: DNDN - ), Genentech (NYSE: DNA - ), and Spectrum
             Pharmaceuticals, Inc. (Nasdaq: SPPI - ) will give presentations at
             Informed Investors Biotech/Cancer Stocks Forum

    When:    December 16, 2003 @ 9:00 AM Eastern Time

    Where:   http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=296

    How:     Live over the Internet -- Simply log on to the web at the address
             above.

    Contacts:
    Aastrom Biosciences -- Investor Relations, 734-930-5777, mail@aastrom.com
    BioCryst Pharmaceuticals -- Michael A. Darwin, 205-444-4600,
     mdarwin@biocryst.com
    Dendreon -- Julie Rathbun, Investor Relations, (206) 829-1500
    Genentech -- Diane Schrick, 650-225-1599, investor.relations@gene.com
    Spectrum Pharmaceuticals -- Anna Kazanchy, kazanchyan@aol.com

If you are unable to participate during the live webcast, the call will be available for replay at http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=296.

Aastrom Biosciences, Inc. is a late-stage development company focused on human cell-based therapies.

BioCryst Pharmaceuticals, Inc. designs and develops novel drugs that block key enzymes essential to disease progression.

Dendreon Corporation is a biotechnology company developing targeted therapies for cancer.

Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs.

Spectrum Pharmaceuticals' primary focus is to develop in-licensed drugs for the treatment and supportive care of cancer patients.

FORUM CONTACT: Janet Scharr, Informed Investors, 804-327-3424, jscharr@wilink.co